Yield10 Bioscience, Inc.
YTENQ
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.99% | 24.31% | 12.35% | -1.22% | 2.67% |
| Total Depreciation and Amortization | -9.09% | -9.59% | 1.39% | -5.26% | 10.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.33% | 3.88% | 5.52% | 12.67% | -23.73% |
| Change in Net Operating Assets | 119.03% | 0.10% | 74.37% | 502.17% | -80.71% |
| Cash from Operations | 36.43% | 47.22% | 34.47% | 15.20% | -15.45% |
| Capital Expenditure | -- | -- | -2,100.00% | 105.56% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -2,100.00% | 105.56% | -100.91% |
| Total Debt Issued | -- | -- | 100.00% | -103.30% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 18.46% | 1,349.45% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -126.92% | -- | -100.00% | -15.01% | 2,480.14% |
| Foreign Exchange rate Adjustments | -75.00% | 122.22% | -1,700.00% | 92.86% | -366.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -388.14% | 117.84% | -463.62% | -8.73% | 196.34% |